Skip to content

A 10 year retrospective clinical study on the balanSys bicondylar total knee endoprosthesis.

A 10 year retrospective clinical study on the balanSys bicondylar total knee endoprosthesis. - balanSys 10 years

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36144
Enrollment
100
Registered
2011-10-10
Start date
2011-09-23
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis primary total knee replacement

Interventions

None listed

Sponsors

Mathys Medical Ltd
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients that received the first series of the BalanSys bicondylar total knee endoprosthesis during the period of 1998 till 2003. Patients are identified through the hospital database.

Exclusion criteria

Exclusion criteria: Patients who refuse to visit the hospital for the study.

Design outcomes

Primary

MeasureTime frame
The primary goal of this study is to determine the 10-years results of at least 50 balanSys total knee arthroplasty (TKA) patients with respect to clinical and radiological outcome. To achieve these goals physical examination, knee and VAS scores, radiological evaluation, subjective questionnaire (KOOS) and a survival analysis are used. Survival analysis Parameters of the clinical and radiological evaluation are: • Range of motion (flexion and extension deficit) • Anterior-posterior laxity • KSS and KOOS • VAS pain and satisfaction • Position of the implant • Radiolucencies

Secondary

MeasureTime frame
Furthermore, a safety analysis including complications and a survival rate of this prosthesis will be made. Complications: - excessive migration of one of the two components - trauma - revision - mobilisation under anaesthesia - infection - patella(sub) luxation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)